Freenome Holdings Inc.
Nasdaq FRNM · Brisbane, CA
Works in GI & liver · Infectious disease · Oncology · Respiratory
Freenome Holdings Inc. is a clinical trial sponsor based in Brisbane, CA, listed as Nasdaq FRNM. It has 1 active clinical trial with 20,000 planned participants, in GI & liver, Infectious disease, Oncology and Respiratory. Since 2021 it has completed 4 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq FRNM
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Freenome Holdings Inc
Freenome Holdings Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 20,000 planned participants, in GI & liver, Infectious disease, Oncology, Respiratory. Since 2021 it has completed 4 trials and stopped 0 early.
Freenome Holdings Inc is based in Brisbane, CA and is listed as Nasdaq FRNM. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Freenome Holdings Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-12-26.
Approve Suite is not affiliated with Freenome Holdings Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.